Le Lézard
Classified in: Health, Business
Subjects: CXP, MAT

Urology Associates Medical Group Offers GAINSWave® in California


BURBANK, Calif., June 4, 2018 /PRNewswire/ -- Urology Associates Medical Group is pleased to announce they now offer GAINSWave! This breakthrough noninvasive medical therapy uses low-intensity shockwave therapy to enhance sexual performance and to treat Erectile Dysfunction (ED) symptoms.

GAINSWave Logo (PRNewsfoto/GAINSWave)

As men age, the vessels in their penis weaken, contract and fill with micro-plaque, which can lead to Erectile Dysfunction. As these tiny vessels become clogged, the penis decreases in sensitivity, making it harder for men to achieve and maintain an erection. Thankfully, the GAINSWave protocols can enhance a man's performance by using high-frequency acoustic waves to repair existing blood vessels and improve blood flow.

Thanks to the numerous clinical studies on Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT), we can see that this therapy improves not only Erectile Dysfunction symptoms but also sexual performance. "GAINSWave is an ideal solution for men looking to improve spontaneous erections without the use of Viagra or Cialis," says Philip Weintraub, MD. Patients receiving GAINSWave therapy have reported improved erection quality, enhanced sexual performance and decreased refractory times between orgasms, which is why this a great alternative to ED medications.

This drug and surgery-free procedure only takes about 20 minutes and can enhance a man's sex life while addressing the root cause of Erectile Dysfunction. Urology Associates Medical Group is now treating men with the GAINSWave Therapy in their offices located at 2601 West Alameda, Suite 416, Burbank, Ca 91505, USA.

Urology Associates Medical is the longest running Urology practice in the San Fernando Valley having been founded in 1946. The practice is located in Burbank, California adjacent to Provident Saint Joseph Medical Center and provides the full range of Urologic care to both male and female patients. Conditions that we treat include prostate enlargement, urologic cancers (prostate, kidney, bladder, and testicle), sexual dysfunction, hormone replacement, stone disease, vasectomy and female urologic problems.

We utilize the latest technology including the DaVinci robot, Gainswave, Urolift, Rezum and Interstim sacral neuromodulation.  We treat the largest number of patients with Peyronie's disease in the western United States. Our emeritus partner, Dr. Martin Gelbard, has been a pioneer in the treatment of Peyronies. We performed the basic research that helped the recent medication, Xiaflex, receive FDA approval for the treatment of this condition. Dr. Gelbard also developed a widely utilized surgical procedure for Peyronie's and, to date, we have surgically corrected more than 500 men with this condition.

For More Information Contact:
Alexandra Schapiro
Marketing Account Manager
[email protected]
305-918-1886

 

SOURCE GAINSWave


These press releases may also interest you

at 06:35
Merck , known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2024. "Merck has begun 2024 with continuing momentum in our business. We are harnessing the power of innovation to advance our...

at 06:35
Sage Therapeutics, Inc. , a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the first quarter ended March 31, 2024. "The launch of ZURZUVAE is off to...

at 06:30
Sage Veterinary Imaging (SVI) has welcomed Peter Selover to its team as president and chief operating officer. Selover had previously served as chief executive officer of Exubrion Therapeutics....

at 06:14
The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments, to expand the global impact and speed up the market penetration of PolyU's...

at 06:09
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Personalized Nutrition Market ? (By Purchase Model (Subscription, One Time Purchase), By End-users (Direct Consumers, Wellness & Fitness Centers,...

at 06:05
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer's disease, macular degeneration, and glaucoma research grant funding?age-related diseases with no cure that affect more than 335 million people worldwide. This year's...



News published on and distributed by: